Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
IRMD · against 478 other Healthcare companies of similar size
Ranked #61 of 479 · scores higher than 87% of peers · safety percentile 89
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)57 peers with a safety percentile of 80–89, including IRMD · Click a bar to see the companies
Mainly thanks to its current ratio, which is stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | IRMD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 452 reported | Not reported | 0.18× | — | — | 33% |
| BetaLower is better · 451 reported | 0.91 | 0.47 | 28% | 33% | |
| Current ratioHigher is better · 468 reported | 9.46× | 2.90× | 85% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 1.1B USD | 100 | ||
| 4 | 1.0B USD | 99 | 35 | |
| 5 | 1.2B USD | 99 | ||
| 57 | 6.5B CNY (≈$911M) | 90 | 62 | |
| 58 | 1.9B USD | 89 | 49 | |
| 59 | 11.3B CNY (≈$1.6B) | 89 | 76 | |
| 60 | 2.21T KRW (≈$1.6B) | 89 | 57 | |
| 61 | 1.0B USD | 89 | 74 | |
| 62 | 650M USD | 88 | 48 | |
| 63 | 7.9B CNY (≈$1.1B) | 88 | 64 | |
| 64 | 996M USD | 88 | 35 | |
| 65 | 6.0B CNY (≈$841M) | 88 | 29 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score